Pfizer-BioNTech Bivalent COVID-19 Vaccine Booster Sharply Reduces Hospitalizations Among Older Patients, Researchers Say

January 10, 2023

Reuters (1/9, Lubell) reports, “The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab’s real...